BAC - General Information & Epidemiology
Epidemiology
of Bronchioloalveolar Carcinoma Over the Past Two Decades: Analysis of
the SEER Database (PubMed)
Abstract of a study published in the August 2004 issue of Lung
Cancer that describes the incidence, demographics,
and overall survival of BAC patients as compared to other NSCLC types
over the past two decades (1979-1998). [8/04]
Prognosis
& Recurrence Patterns in Bronchioloalveolar Carcinoma (FindArticles.com)
Yung-Yang Liu et al.
v. 118 CHEST (October 2000): 940-947
Full text article analyzing the initial radiographic findings, TNM
stagings, surgical types, and radiologic features of recurrence, and correlate
them with patient survival. Concludes that patients with localized, early
stage BAC who underwent curative surgery had a better survival. Patients
with localized recurrence after the initial surgery warranted a second
resection. Those with a diffuse radiologic pattern of recurrence and/or
early recurrence had a worse prognosis. [10/00]
BAC
& Prognosis - Recent MEDLINE Abstracts
LUNG-BAC
(Association of Cancer Online Resources)
Online discussion group for BAC patients, families and caregivers.
BAC
Study - You Can Participate! (Harvard School of Public
Health)
Research study to investigate the nature and cause of bronchioloalveolar
carcinoma (BAC) with the aim of developing prevention measures and more
effective treatments for this rare type of lung cancer. If you have been
diagnosed with BAC or adenocarcinoma with "BAC features," you
may be eligible to participate. A detailed description of the study is
available online.
Additional information may be obtained by contacting the study coordinator,
Emily Logan, by e-mail: elogan@hsph.harvard.edu
or by phone: 617-432-1261. [n.b. Study funded by The Lung Cancer
Online Foundation.]
BAC - Pathology & Diagnostic
Dilemmas
BAC
Pathology - Recent MEDLINE Abstracts (PubMed)
Bronchioloalveolar
Carcinoma Masquerading as Pneumonia (cancernetwork.com)
by Collette M. Hodges, RN, and Gregory P. Kalemkerian, MD
20, no.7 Primary Care & Cancer (July/August 2000)
Describes bronchioloalveolar carcinoma (BAC), including its epidemiology
and etiology, clinical presentation, radiographic features, pathology,
diagnosis and staging, treatment and prognosis, and case reports. Aimed
at physicians. Registration required for free access to cancernetwork.com.
[8/00]
Fine-needle
Aspiration Biopsy of Bronchioloalveolar Carcinoma (PubMed)
Abstract of a study evaluating the accuracy of the cytologic diagnosis
of bronchioloalveolar carcinoma (BAC) by fine-needle aspiration biopsy
(FNAB). [2/01]
Treatment of BAC
Treatment
Options for Bronchioloalveolar Carcinoma (BAC) (Medscape)
Vincent Miller, MD, describes the various forms of BAC and recommends
treatment options. Aimed at health care professionals. Registration required
for free access to Medscape. [9/03]
Bronchioloalveolar
Carcinoma (PubMed)
Abstract of a study published in the June 15, 2004 issue of Clinical
Cancer Research that reviews recent incidence and treatment data
in bronchioloalveolar carcinoma (BAC). Presents clinical data and preliminary
study results to suggest that BAC provides a useful model for studying
predictive markers of epidermal growth factor receptor (EGFR) inhibition.
[6/04]
Gefitinib
(Iressa; ZD1839) Therapy for Advanced BAC (ASCO)
Abstract of a study presented at the 2004 ASCO annual meeting that
found gefitinib is active as a single agent in both untreated and previously
treated patients with advanced bronchioloalveolar carcinoma (BAC). [6/04]
New
Drug Shows Promise in Treating Patients with BAC (People
Living With Cancer)
Reports on a Phase II study presented at the 2003 ASCO annual meeting
that found the targeted drug erlotinib (Tarceva) showed encouraging results
in patients with BAC. In 30 patients with BAC who had been treated with
erlotinib for one month or more, eight (27%) responded to the drug. Researchers
also found that erlotinib was more effective in patients who had never
smoked. [5/03]
Asymptomatic
Recurrent Bronchioloalveolar Adenocarcinoma? (Medscape)
Discusses BAC and its characteristics. Addresses the issue of treatment
for asymptomatic recurrence Registration required for free access to Medscape.
[1/02]
Frequent EGFR Mutations in Noninvasive Bronchioloalveolar Carcinoma (PubMed)
Abstract of an article published in the December 13, 2005 issue of the Int J Cancer that reports on the frequent occurrence of epidermal growth factor receptor (EGFR) gene mutations in noninvasive bronchioloalveolar carcinoma (BAC). [12/05]
BAC
& Treatment with EGFR Inhibitors (Iressa & Tarceva) - Recent MEDLINE
Abstracts
BAC
& Surgery - Recent MEDLINE Abstracts
BAC
& Lung Transplantation - Recent MEDLINE Abstracts
BAC - Clinical Trials
BAC
(or Adenocarcinoma w/BAC Features) Clinical Trial (Millennium
Pharmaceuticals)
|
